Why Is Profusa Stock Falling Monday?
PFSA stock fell 18.5% in premarket trading after Profusa named a new CEO and signed a deal to acquire a $111M diagnostics firm.
Share
Why It Matters
Profusa got a new leader and bought another company to help with health testing. When big changes happen fast, some investors get nervous and sell, even if the moves might be good long-term.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.
